Henry Lu
Corporate Officer/Principal bij WUXI APPTEC CO., LTD.
Profiel
Henry Lu is currently the Vice President & Head-Biology at WuXi AppTec Co., Ltd.
Prior to this, he worked as the Senior Director-Infectious Diseases at Rigel Pharmaceuticals, Inc. and as a Principal Scientist at Novartis Corp.
He also served as an Adjunct Associate Professor at The University of California, San Francisco.
Dr. Lu received his undergraduate degree from Fudan University and his doctorate from Academia Sinica.
Actieve functies van Henry Lu
| Bedrijven | Functie | Begin |
|---|---|---|
| WUXI APPTEC CO., LTD. | Corporate Officer/Principal | 03-08-2011 |
Eerdere bekende functies van Henry Lu
| Bedrijven | Functie | Einde |
|---|---|---|
| RIGEL PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Novartis Corp.
 Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Corporate Officer/Principal | - |
| The University of California, San Francisco | Corporate Officer/Principal | - |
Opleiding van Henry Lu
| Fudan University | Undergraduate Degree |
| Academia Sinica | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| RIGEL PHARMACEUTICALS, INC. | Health Technology |
| WUXI APPTEC CO., LTD. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Health Technology |
